Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel M Rubinstein

Showing results (11-20 of 56) with videos related to

Pageof 6
Sort By:
Lancet (London, England)|October 11, 2020
Cancer and COVID-19 - Authors' replyNicole M Kuderer, Elizabeth Wulff-Burchfield, Samuel M Rubinstein, et al.
Transfusion|March 25, 2021
A retrospective cost analysis of the frequency and cost of transfusion premedicationsBradley W Christensen, Samuel M Rubinstein, Dikshya Bastakoty, et al.
JAMA Network Open|December 14, 2019
Indication of Measures of Uncertainty for Statistical Significance in Abstracts of Published Oncology Trials: A Systematic Review and Meta-analysisSamuel M Rubinstein, Elizabeth A Sigworth, Shervin Etemad, et al.
Cancer Cell|May 27, 2020
The COVID-19 and Cancer Consortium: A Collaborative Effort to Understand the Effects of COVID-19 on Patients with CancerSamuel M Rubinstein, John A Steinharter, Jeremy Warner, et al.
Seminars in Radiation Oncology|September 2, 2019
The Evolving Use of Electronic Health Records (EHR) for ResearchEllen Kim, Samuel M Rubinstein, Kevin T Nead, et al.
Iscience|April 1, 2022
Development of a bayesian toxo-equivalence model between docetaxel and paclitaxelElizabeth A Sigworth, Samuel M Rubinstein, Sandip Chaugai, et al.
International Journal of Molecular Sciences|July 27, 2024
Differential Expression of Circulating miRNAs and Carfilzomib-Related Cardiovascular Adverse Events in Patients with Multiple MyelomaMarwa Tantawy, Taimour Langaee, Danxin Wang, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 17, 2024
Second Line Therapy in Multiple Myeloma: A SEER Medicare AnalysisMatthew R LeBlanc, Xi Zhou, Christopher D Baggett, et al.
JCO Clinical Cancer Informatics|January 7, 2021
Chemotherapy Knowledge Base Management in the Era of Precision OncologySamuel M Rubinstein, Tarsheen Sethi, Neeta K Venepalli, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 21, 2016
Immune-Mediated Complications after Hematopoietic Stem Cell TransplantationZhuoyan Li, Samuel M Rubinstein, Ramya Thota, et al.
Pageof 6

Showing results (11-20 of 56) with videos related to

Sort By:
Pageof 6
Lancet (London, England)|October 11, 2020
Cancer and COVID-19 - Authors' replyNicole M Kuderer, Elizabeth Wulff-Burchfield, Samuel M Rubinstein, et al.
Transfusion|March 25, 2021
A retrospective cost analysis of the frequency and cost of transfusion premedicationsBradley W Christensen, Samuel M Rubinstein, Dikshya Bastakoty, et al.
JAMA Network Open|December 14, 2019
Indication of Measures of Uncertainty for Statistical Significance in Abstracts of Published Oncology Trials: A Systematic Review and Meta-analysisSamuel M Rubinstein, Elizabeth A Sigworth, Shervin Etemad, et al.
Cancer Cell|May 27, 2020
The COVID-19 and Cancer Consortium: A Collaborative Effort to Understand the Effects of COVID-19 on Patients with CancerSamuel M Rubinstein, John A Steinharter, Jeremy Warner, et al.
Seminars in Radiation Oncology|September 2, 2019
The Evolving Use of Electronic Health Records (EHR) for ResearchEllen Kim, Samuel M Rubinstein, Kevin T Nead, et al.
Iscience|April 1, 2022
Development of a bayesian toxo-equivalence model between docetaxel and paclitaxelElizabeth A Sigworth, Samuel M Rubinstein, Sandip Chaugai, et al.
International Journal of Molecular Sciences|July 27, 2024
Differential Expression of Circulating miRNAs and Carfilzomib-Related Cardiovascular Adverse Events in Patients with Multiple MyelomaMarwa Tantawy, Taimour Langaee, Danxin Wang, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 17, 2024
Second Line Therapy in Multiple Myeloma: A SEER Medicare AnalysisMatthew R LeBlanc, Xi Zhou, Christopher D Baggett, et al.
JCO Clinical Cancer Informatics|January 7, 2021
Chemotherapy Knowledge Base Management in the Era of Precision OncologySamuel M Rubinstein, Tarsheen Sethi, Neeta K Venepalli, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 21, 2016
Immune-Mediated Complications after Hematopoietic Stem Cell TransplantationZhuoyan Li, Samuel M Rubinstein, Ramya Thota, et al.
Pageof 6